Copyright
©The Author(s) 2017.
World J Gastroenterol. Aug 28, 2017; 23(32): 5986-5993
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5986
Published online Aug 28, 2017. doi: 10.3748/wjg.v23.i32.5986
Group A ( fixed time split dose preparation) n = 99 | Group B (split dose preparation) n = 105 | P value | |
Male: Female | 61:38 | 57:48 | NS |
Mean age, r | 54.6 ± 11.5 | 54.3 ± 9.4 | NS |
Age ≥ 65 | 20 (20.2) | 16 (15.2) | NS |
Weight (kg) | 64.7 ± 11.7 | 65.4 ± 11.3 | NS |
BMI (kg/m2) | 23.8 ± 3.05 | 24.2 ± 2.88 | NS |
BMI ≥ 30 | 4 (4) | 4 (3.8) | NS |
History of abdominal surgery | 7 (7.1) | 7 (6.7) | NS |
History of Diabetus mellitus | 8 (8.1) | 12 (11.4) | NS |
- Citation: Jun JH, Han KH, Park JK, Seo HI, Kim YD, Lee SJ, Jun BG, Hwang MS, Park YK, Kim MJ, Cheon GJ. Randomized clinical trial comparing fixed-time split dosing and split dosing of oral Picosulfate regimen for bowel preparation. World J Gastroenterol 2017; 23(32): 5986-5993
- URL: https://www.wjgnet.com/1007-9327/full/v23/i32/5986.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i32.5986